SEC 8-K and 6-K filings classified by Claude with reasoning, plus Form 4 insider transactions. Ingested from EDGAR’s filing stream in near-real time, reconciled overnight.
Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
Capstone retired approximately 85% of its convertible note principal ($5.82M of $6.82M) through a combination of convertible note conversions (2.4 million shares) and an equity line of credit with Tumim Stone Capital (3.4 million shares), resulting in a material 28% increase in outstanding shares and a strengthened capital structure with elimination of convertible debt overhang.
View raw filing on EDGAR →The Company increased the maximum aggregate offering price under an at-the-market (ATM) sales agreement with Benchmark and StoneX by $966,000 to a total of $5,465,000. This is a dilutive equity issuance under an ATM offering facility, which is a material capital-raising activity that increases share dilution and is commonly disclosed as Item 8.01 for ATM program updates.
View raw filing on EDGAR →In connection with the financing, Onar issued 9,202,613 shares of Common Stock as incentive shares and Warrants exercisable for 102,251,256 shares, all offered and sold in reliance on Section 4(a)(2) and Rule 506 in a private placement at a $25 million pre-money valuation.
View raw filing on EDGAR →Liberty Star entered into a Securities Purchase Agreement with Monroe Street Capital Partners LP to issue a convertible promissory note with principal amount of $95,700 (including 10% original issue discount). The note is convertible into shares of common stock, making this a dilutive equity issuance. While Item 1.01 frames this as a "material definitive agreement" and Item 2.03 addresses the debt obligation, the core economic substance is an unregistered convertible debt issuance that will dilute existing shareholders upon conversion.
View raw filing on EDGAR →The filing discloses an exchange of $1.2 million in debt principal for 120 shares of newly designated Series B Preferred Stock at $10,000 per share, pursuant to an Exchange Agreement dated September 28, 2026. This represents an unregistered issuance of equity securities under Section 4(a)(2) of the Securities Act, with the preferred shares carrying an 8% annual return and redemption rights. The transaction is material as it increases the company's equity base and dilutes existing shareholders while converting debt to equity.
View raw filing on EDGAR →The exhibit announces the closing of an underwriter's over-allotment option exercise, resulting in the sale of 648,373 Class A ordinary shares at $1.15 per share for approximately $745,629 in gross proceeds. This is a dilutive equity issuance in connection with a public offering (Form F-1), bringing total offering proceeds to approximately $5.7 million. The company explicitly states it is raising capital through registered public equity issuance, which is material to investors assessing ownership dilution and capital structure.
View raw filing on EDGAR →The filing discloses unregistered issuances of common stock totaling approximately 918,114 shares (pre-split) in exchange for preferred stock held by existing shareholders, relying on Section 3(a)(9) of the Securities Act. These exchanges are dilutive to existing common shareholders and represent material capital transactions, particularly the September 23 issuances to unaffiliated investors and Stilwell Investors (a related party through board member Joseph Stilwell). The Item 3.02 disclosure and the magnitude of shares issued (21,022 post-split from the September 8 transaction alone) confirm materiality.
View raw filing on EDGAR →BuzzFeed entered into a Share Purchase Agreement with Allen Family Digital, LLC to issue 4,300,000 newly issued shares of Class A common stock at $1.09 per share, raising approximately $4.7 million in a private placement exempt under Section 4(a)(2) of the Securities Act.
View raw filing on EDGAR →Blackstone Private Equity Strategies Fund L.P. and its feeder fund completed unregistered sales of limited partnership units totaling approximately $694.3 million in aggregate consideration ($527.9 million by BXPE U.S. and $166.4 million by the Feeder) to accredited investors and qualified purchasers on September 1, 2026, pursuant to Section 4(a)(2) and Regulation D exemptions.
View raw filing on EDGAR →Blackstone Infrastructure Strategies L.P. and its feeder fund sold approximately $366.4 million in unregistered limited partnership units on September 1, 2026, to accredited investors and qualified purchasers pursuant to Section 4(a)(2) and Regulation D exemptions.
View raw filing on EDGAR →Stonepeak-Plus Infrastructure Fund LP sold approximately $52.7 million in unregistered limited partnership units to third-party investors on September 1, 2026, pursuant to Section 4(a)(2) and Regulation D exemptions. This private placement represents a significant capital raise and dilution event for the Fund.
View raw filing on EDGAR →Largo Inc. completed a registered direct offering of 10.2 million common shares and 10.2 million investor warrants plus 539,000 placement agent warrants at $0.56 per unit for aggregate gross proceeds of $5.7 million under an effective Form F-3 shelf registration statement, with insiders ARC Fund IV and Jim Bannantine participating. The offering materially dilutes existing shareholders and the company intends to use proceeds for working capital and trade creditor payments.
View raw filing on EDGAR →Eagle Point Trinity Senior Secured Lending Co issued 910.51 common shares for $9,325 in aggregate proceeds pursuant to subscription agreements, with the offer and sale exempt from Securities Act registration under Section 4(a)(2), Regulation D, and/or Regulation S.
View raw filing on EDGAR →On September 25, 2026, Jaguar Health exchanged 481,584 shares of common stock for a $3.4 million reduction in the outstanding balance of a secured promissory note originally issued in 2021. The shares were issued as unregistered securities under Section 3(a)(9) of the Securities Act, representing a dilutive equity issuance that materially affects the company's capital structure and shareholder equity.
View raw filing on EDGAR →This Appendix 2A filing discloses the conversion of 106,175 employee performance rights (NVX:AD) into 74,694 ordinary fully paid shares (NVX) on 28 September 2026. While the immediate dilution from this single conversion event is modest (~0.007% of outstanding shares), the filing reveals substantial unquoted convertible securities on issue (45.2M convertible notes, 35M convertible debentures, 20.6M performance rights, 14M options), creating material future dilution risk. The conversion of equity-linked securities and the disclosure of the company's significant convertible capital structure would affect a reasonable investor's assessment of dilution exposure.
View raw filing on EDGAR →Strategy Inc sold 1,469,165 shares of Class A Common Stock under an at-the-market offering program, generating $246.2 million in net proceeds. The proceeds were deployed for bitcoin purchases and preferred stock repurchases, representing a material capital-raising activity that dilutes existing shareholders.
View raw filing on EDGAR →ADARx completed its IPO on September 28, 2026, issuing 26.25 million registered shares at $17.00 per share for approximately $446.3 million in gross proceeds, concurrent with a private placement of 5,255,542 unregistered shares to AbbVie Inc. at the same price for approximately $89.3 million. The combined equity issuance of approximately $535.6 million represents a material capital raise and significant dilution to existing shareholders.
View raw filing on EDGAR →The Trust issued 151,900 shares in private placement transactions to accredited investors pursuant to Rule 506(c) of Regulation D, exempt from Securities Act registration. The filing explicitly discloses unregistered equity sales totaling $891,272 in aggregate value, with Grayscale Securities acting as Authorized Participant and potential underwriter. This is a classic dilutive issuance under Item 3.02, material to investors as it increases share count and dilutes existing holders.
View raw filing on EDGAR →Summit Therapeutics entered into a securities purchase agreement with AstraZeneca for a $2.0 billion private placement of 108,955.3686 shares of Class A Convertible Preferred Stock, convertible into common stock at a 1:1,000 ratio ($18.36 per share equivalent). The unregistered securities were issued under Section 4(a)(2) and Regulation D exemptions, with Summit agreeing to file a registration statement for resale of the underlying common shares.
View raw filing on EDGAR →In connection with the business combination, Bold Eagle is issuing unregistered equity securities including PubCo Common Stock, PIPE Shares, Convertible Notes, and Underlying Shares pursuant to Subscription Agreements, representing $335 million of committed capital ($275 million in convertible notes and $60 million in common stock PIPE), all relying on Section 4(a)(2) exemption.
View raw filing on EDGAR →The 6-K discloses entry into a securities purchase agreement on September 28, 2026, for the issuance of 11,750,072 ordinary shares at US$1.27 per share, generating gross proceeds of approximately US$14.9 million. The shares are being offered to non-U.S. persons in reliance on Regulation S and have not been registered under the Securities Act, making this an unregistered private placement — a classic dilutive issuance. The magnitude (11.75 million shares) and capital raised (US$14.9 million) are material to a reasonable investor's assessment of the registrant's capitalization and ownership structure.
View raw filing on EDGAR →Proem issued approximately $50 million in unregistered Parent Common Shares to PIPE investors pursuant to PIPE Subscription Agreements, relying on Section 4(a)(2) and Regulation D exemptions, with Proem Asset Management and affiliates committing $25 million of the total.
View raw filing on EDGAR →This press release announces an underwritten registered direct offering of 833,334 ordinary shares at $0.60 per share and pre-funded warrants to purchase 24,166,666 ordinary shares at $0.5999 per share, raising approximately $15 million in gross proceeds. The offering involves registered securities sold directly to investors, which is a classic dilutive equity issuance. The company explicitly states the offering is being made pursuant to an effective Form F-3 registration statement, and the securities are being offered to the public, making this a material capital-raising event that would affect a reasonable investor's assessment of ownership dilution and the company's financial position.
View raw filing on EDGAR →The press release announces a private placement of 667,000 Class A ordinary shares at US$1.50 per share for aggregate gross proceeds of approximately US$1.0 million, plus Series A and Series B warrants for no additional consideration. This is an unregistered sale of equity securities in reliance on exemptions from registration under the Securities Act of 1933, which is a classic dilutive issuance. The transaction is material as it raises capital and dilutes existing shareholders' ownership stakes.
View raw filing on EDGAR →The press release announces the closing of a public offering of 12,000,000 Class A ordinary shares at $0.80 per share, generating approximately $9,600,000 in gross proceeds. This is a registered follow-on public offering (Form F-1) that dilutes existing shareholders. The offering is material to investors as it represents a significant capital raise and equity dilution event.
View raw filing on EDGAR →The Company entered into a securities purchase agreement to sell 1,320,000 shares of common stock in a direct registered offering to institutional investors, generating approximately $17.2 million in net proceeds. This is a material dilutive equity issuance to raise capital for mining operations and working capital, filed under Item 1.01 as a material definitive agreement. The disclosure also notes termination of a prior ATM program, further confirming the capital-raising nature of this transaction.
View raw filing on EDGAR →AZIO AI Holdings entered into a Standby Equity Purchase Agreement (SEPA) with YA II PN, Ltd. providing for up to $50 million in equity financing through convertible promissory notes ($3.5 million pre-paid advance), warrants for 1,735,758 shares at $0.01 exercise price, and commitment to purchase up to $50 million of common stock, contemplating issuance of up to 28 million shares subject to a 19.99% Exchange Cap. The unregistered securities were issued in reliance on Section 4(a)(2) exemption, representing a significant dilutive private placement.
View raw filing on EDGAR →Draganfly announces a registered direct offering of 1,869,159 common shares at US$5.35 per share for gross proceeds of approximately US$10 million. This is an unregistered equity issuance (though registered under Form F-10) that dilutes existing shareholders. The investment is from Unusual Machines (NYSE American: UMAC) and a leading U.S. Investment Fund, each investing $5M, representing a material capital raise that would affect investor assessment of ownership dilution and the company's strategic positioning.
View raw filing on EDGAR →Azitra entered into an at-the-market (ATM) sales agreement with A.G.P./Alliance Global Partners on September 28, 2026, permitting the issuance of up to $3.5 million in common stock shares. This is a classic dilutive equity issuance under an effective S-3 registration statement, with the Company retaining discretion to sell shares over time through an agent. The 3.0% commission structure and use of proceeds for working capital are typical ATM characteristics, and such offerings materially dilute existing shareholders and signal capital-raising activity.
View raw filing on EDGAR →WeShop entered into an Ordinary Shares Purchase Agreement with Roth Principal Investments on September 9, 2026, granting the Company the right to sell up to $25,000,000 of newly issued Class A ordinary shares at the Company's sole discretion over 36 months. This is a classic at-the-market (ATM) or equity line of credit arrangement—an unregistered continuous offering of equity securities. The filing explicitly notes the transaction is subject to Nasdaq's 19.99% Exchange Cap limitation and contemplates potential shareholder approval or reliance on foreign private issuer exemptions, confirming the dilutive nature. The $500,000 commitment fee and $75,000 legal reimbursement further evidence a material capital-raising transaction.
View raw filing on EDGAR →J-Star entered into an equity purchase agreement with Hudson Global Ventures on September 24, 2026, granting the investor the right to purchase up to $35 million of Class A ordinary shares over 36 months at a discounted price (95% of average of three lowest traded prices), plus warrants for 525,000 shares. This is a classic at-the-market (ATM) or PIPE-like arrangement that creates significant dilution risk to existing shareholders and is material to investor assessment of capital structure and ownership.
View raw filing on EDGAR →The filing discloses an exchange agreement in which CEO Arthur Sams converted $614,700 of debt into 683 shares of Series A Convertible Preferred Stock and a warrant to purchase 382,276 common shares. While structured as a debt-to-equity conversion, Item 3.02 explicitly incorporates the disclosure, and the press release emphasizes the issuance of equity securities (preferred shares and warrants) to address balance sheet and Nasdaq compliance issues. This is a material dilutive issuance of equity, though the debt conversion aspect is also significant.
View raw filing on EDGAR →Julong announced a private placement of 750,000 Class A ordinary shares at US$0.300 per share and 2,250,000 pre-funded warrants at US$0.299 per warrant, generating gross proceeds of US$897,750. This is an unregistered sale of equity securities under Regulation D, with the securities explicitly stated as not registered under the Securities Act of 1933. The pre-funded warrants are immediately exercisable at US$0.001 per share, creating significant dilution to existing shareholders. This is a classic dilutive issuance event material to investors assessing the registrant's capital structure and ownership.
View raw filing on EDGAR →Wintergreen Acquisition Corp. completed an unregistered sale of equity securities involving a convertible note with underlying units issuable upon conversion, subject to transfer restrictions on the sponsor's securities until completion of the business combination and registration rights.
View raw filing on EDGAR →BlackRock Private Credit Fund disclosed an unregistered sale of 107,475.86 Institutional Class Shares for $2,540,654 to feeder vehicles, exempt under Section 4(a)(2) and Regulation S, increasing share count and diluting existing holders' ownership interests.
View raw filing on EDGAR →Hafnia Limited successfully completed a registered public offering of 35,488,875 ordinary shares, raising approximately USD 300 million in gross proceeds. The offering was executed pursuant to a prospectus supplement filed under an effective Form F-3 shelf registration statement, with legal opinions confirming the transaction structure.
View raw filing on EDGAR →IM Cannabis closed a registered direct offering of 655,000 common shares at US$2.00 per share, raising US$1.31 million in gross proceeds. This is a registered equity issuance to accredited investors under an effective Form F-3 shelf registration statement. The disclosure explicitly notes the Company was in "serious financial difficulty" and relied on MI 61-101 exemptions based on financial hardship, indicating material dilution to existing shareholders and capital-raising necessity typical of small-cap issuers under financial stress.
View raw filing on EDGAR →Silver Point Private Credit Fund conducted an unregistered sale of 902,356 common shares for $24.3 million at $26.94 per share pursuant to subscription agreements, exempt under Section 4(a)(2) and Regulation D.
View raw filing on EDGAR →Apollo Infrastructure Co LLC completed an unregistered private placement of approximately $68.1 million in equity securities across multiple share classes (Series I and Series II A-II, F-I, E, and I Shares) to third-party investors, issuing over 2.2 million shares under Section 4(a)(2) and Regulations D and S exemptions.
View raw filing on EDGAR →The Fund sold 192,455 unregistered Class I common shares to feeder vehicles for $5.0 million, relying on Section 4(a)(2) and Regulation S exemptions from Securities Act registration.
View raw filing on EDGAR →KLX completed a $125 million subscription rights offering resulting in the issuance of approximately 24.975 million shares at $1.49 per share, plus an additional ~59.3 million shares issued in a backstop exchange of 2030 Notes, increasing pro forma share count from ~80.4 million to ~105.7 million shares. This substantial dilutive equity issuance was undertaken to raise capital and reduce debt obligations.
View raw filing on EDGAR →Apollo Asset Backed Credit Co LLC conducted unregistered sales of equity securities totaling approximately $24.9 million across Series I and Series II share classes to third-party investors as of September 1, 2026, under Section 4(a)(2), Regulation D, and Regulation S exemptions. The issuance of over 1 million shares across multiple classes represents material capital raising activity affecting ownership dilution and capital structure.
View raw filing on EDGAR →On September 25, 2026, Arbe Robotics amended existing warrant agreements covering 16.3 million ordinary shares, reducing exercise prices (Tranche A to $1.10, Tranche B to $1.00) and extending termination dates to 2029–2030. These amendments make the warrants more likely to be exercised and dilute existing shareholders. While the warrants were originally issued in November 2024, the material amendment reducing exercise prices and extending expiration dates constitutes a dilutive capital event that would affect a reasonable investor's assessment of share dilution risk.
View raw filing on EDGAR →Star Fashion Culture Holdings Ltd announced the pricing of a follow-on public offering of 12,000,000 Class A ordinary shares at $0.80 per share, generating approximately $9.6 million in gross proceeds. The company intends to use proceeds for online marketing services development and general working capital.
View raw filing on EDGAR →The 6-K discloses entry into a Securities Purchase Agreement for a registered direct offering of 10,000,000 Class A Shares at $1.50 per share plus 10,000,000 Warrants at $2.75 exercise price, with an over-allotment option exercised on September 24–25, 2026 for an additional 550,000 shares and warrants. This is a dilutive equity issuance raising approximately $15.825 million in gross proceeds, materially affecting shareholder ownership and the capital structure.
View raw filing on EDGAR →Healthcare Triangle entered into a First Amendment to an Equity Purchase Agreement with Hudson Global Ventures on September 22, 2026, modifying key terms of a June 2026 equity arrangement. The Amendment restructures the put-right mechanics (reducing maximum put amount from $2.5M to $250K per notice, raising minimum price per share from $0.01 to $0.10) and adds a Change of Control provision. While the filing does not explicitly state the total equity issuance amount or fully disclose the original agreement's structure, the amendment to an equity purchase agreement involving a private investor constitutes a material modification to a dilutive capital arrangement. The reduction in maximum put amount and increase in minimum price suggest negotiated adjustments to an existing equity commitment, consistent with dilutive issuance disclosure obligations under Item 3.02 or Item 1.01 for material definitive agreements.
View raw filing on EDGAR →The Company issued 2,157,340 shares of common stock (698,113 + 1,459,227 shares) to Lind Global Asset Management in satisfaction of conversion obligations under a senior secured convertible note. The issuance was made in reliance on Section 3(a)(9) and Section 4(a)(2) exemptions and Rule 506 of Regulation D, characteristic of unregistered equity issuances. This represents a material dilutive event to existing shareholders and is properly classified under Item 3.02.
View raw filing on EDGAR →Fusion Fuel Green PLC entered into a Share Exchange Agreement on September 23, 2026, to issue 500,000 Class A ordinary shares valued at $2,000,000 to three third-party investors. The shares are unregistered, issued in reliance on Section 4(a)(2), Regulation D, and/or Regulation S exemptions, and are restricted securities. This is a classic private placement of equity securities by a public company, materially dilutive to existing shareholders and a significant capital-raising event.
View raw filing on EDGAR →BOXABL entered into an ATM (at-the-market) Sales Agreement on September 25, 2026, authorizing the sale of up to $100 million in Class A common stock through multiple agents. This is a classic dilutive equity issuance disclosed under Item 1.01, creating a direct financial obligation and potential shareholder dilution. The magnitude ($100M) and structure (unregistered at-market offering) make this material to investors assessing capital structure and ownership stakes.
View raw filing on EDGAR →Maplebear Inc. issued 5,833,333 shares of common stock to an existing preferred stockholder upon conversion of Series A Convertible Preferred Stock. Although the conversion is contractually exempt under Section 3(a)(9), the resulting issuance of a substantial number of common shares with a 35-day transfer restriction represents a material dilutive equity issuance affecting ownership structure and voting power.
View raw filing on EDGAR →